Halozyme
HALO
131 hedge funds and large institutions have $1.1B invested in Halozyme in 2014 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 30 reducing their positions, and 15 closing their positions.
87% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 15
80% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 30
10% more funds holding
Funds holding: 119 → 131 (+12)
6% less call options, than puts
Call options by funds: $11.8M | Put options by funds: $12.5M
8% less capital invested
Capital invested by funds: $1.2B → $1.1B (-$97.7M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$15.8M |
| 2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$13.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$9.71M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$8.89M |
| 2 |
JP Morgan Chase
New York
|
-$6.21M |
| 3 |
SLF
Sun Life Financial
Toronto,
Ontario, Canada
|
-$5.74M |
| 4 |
HH
HWG Holdings
Houston,
Texas
|
-$2.84M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.65M |
HALO Hedge Fund Activity: Q1 2014 in Review
131 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q1 2014, worth a combined $1.1B — down 8.1% from $1.2B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new HALO positions and 15 closed out — a net gain of 13 holders — while 54 added to existing stakes and 30 trimmed.
The largest buyer was Iridian Asset Management, adding an estimated $15.8M. The largest seller was Baker Bros. Advisors, cutting an estimated $8.89M.
- 131 institutional investors held Halozyme (HALO) as of Q1 2014, up from 119 in Q4 2013.
- Funds reported $1.1B of Halozyme stock for Q1 2014, down 8.1% quarter-over-quarter.
- 28 funds opened new Halozyme positions in Q1 2014 and 15 closed out, a net change of +13 holders.
- The largest Halozyme buyer in Q1 2014 was Iridian Asset Management, an estimated $15.8M added.
- The largest Halozyme seller in Q1 2014 was Baker Bros. Advisors, an estimated $8.89M sold.
Based on aggregated 13F filings for Q1 2014.